One Trading Secures Landmark Regulatory Approval for European Crypto Derivatives Trading
One Trading, a leading European crypto-asset exchange, has been granted an Organised Trading Facility (OTF) License by the Dutch financial market regulator. This license establishes One Trading as a MiFID II trading venue and marks a significant milestone in the company's multi-year journey with the Dutch Financial Markets Authority (AFM) and the Dutch Central Bank (DNB) to revolutionize the trading of derivatives and bring crypto futures onshore in the EU.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240729953947/en/
Joshua Barraclough - Founder and CEO of One Trading (Photo: Business Wire)
Transforming Derivatives Trading in Europe
With the new license, One Trading becomes the only perpetual futures trading venue in the EU and the first cash-settled perpetuals platform in Europe, including the UK. This approval establishes One Trading as the first regulated derivatives exchange in Europe accessible to retail clients.
In addition, One Trading is onshoring crypto derivatives as “traded on a trading venue” instruments, further enhancing the regulatory framework and security for European customers. The products that One Trading is rolling out are the modern alternative to products provided by traditional futures venues such as the CME or Eurex, but are simpler, more precise, and far more capital efficient than traditionally cleared derivatives such as dated futures.
Innovative and Proprietary Technology
One Trading's technical implementation of perpetual futures sets it apart as the first trading venue in the world to offer real-time (<1-minute tick level) settlement of all derivatives positions, 24/7 on all markets. This groundbreaking capability complements the proprietary technology already developed to provide the fastest and most scalable spot trading venue globally. One Trading’s technology seamlessly integrates custody and settlement on DLT, making it the first EU venue to allow the use of crypto-assets as collateral for trading regulated financial instruments.
Comprehensive and Integrated Clearing and Settlement
As the only regulated exchange that integrates derivatives product creation and trading without the need for external clearing, One Trading offers an unmatched suite of services which are all directly available to professional and retail clients. With DLT infrastructure mobilising collateral t+0 and 24/7, One Trading challenges existing financial market infrastructure as the first to eliminate costly post-trade processes in favour of a clear, safe, and robust structure focused on helping all clients get the exposures they want - and nothing more. This integrated approach is brought to life in a highly regulated environment by use of leading technology, making it a unique and hard-to-replicate model within MiFID II.
Joshua Barraclough, Founder and CEO of One Trading commented,"We are thrilled to have achieved this milestone, which represents the culmination of years of hard work and innovation. The long-term vision of the company is to enable all customer types to go long or short on any asset, use any asset as collateral, settle everything instantly, and perpetually roll contracts. Our team has been dedicated to developing a platform that not only meets but exceeds the highest regulatory standards. With this licence, we are well positioned to introduce new regulated products and offer institutional-grade solutions to all customer types starting with BTC and ETH products where no onshore EU regulated venue currently exists. This is just the beginning of our journey to redefine the landscape of digital asset and traditional security trading."
A Significant Achievement in Regulatory Approvals
Receiving the first new Organised Trading Facility license granted in the EU in the past three years underscores the rigorous standards One Trading achieved. This reflects the company's innovative approach and trusted leadership, as well as its dedication to reshaping how regulated financial instruments are traded in the digital age.
General Counsel Mario Hoessl-Neumann added: “It has been a great experience working very closely with the Dutch regulators throughout much of this process, and we appreciate their vision and foresight to bring a new market structure for regulated derivatives trading to the EU. By launching a novel form of financial instruments with purpose-built tech and the seamless integration of DLT-based assets on the One Trading platform, we are not just providing European clients with the first onshore alternative to unregulated exchanges. More fundamentally, we are complementing - and in some important ways replacing - traditional structures for how regulated derivatives such as futures are traded. It has always been a core value to us to maintain equal capabilities for professional and retail clients, and it is great to see that we are now first in Europe to bring to life a trading venue that truly works for all.”
One Trading has been advised on its license application by A&O Shearman (Alexander Behrens) and Freshfields Bruckhaus Deringer (Daphne van der Houwen and Stephan Pachinger).
About One Trading
One Trading is a European digital asset exchange headquartered in the Netherlands. The company is committed to providing a secure, fast, and scalable platform for trading crypto-assets and derivatives. With a focus on innovation and regulatory compliance, One Trading aims to set new standards in the industry and offer unparalleled services to its customers. For more information, please visit our website, X, or LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240729953947/en/
Contacts
Eterna Partners for One Trading
eternapartners@onetrading.com
+447762943498
press@onetrading.com
+447795433650
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Visa Unveils New Global Stablecoins Advisory Practice15.12.2025 13:00:00 CET | Press Release
Visa (NYSE: V), a global leader in digital payments, today announced the launch of its Stablecoins Advisory Practice. The new value-added service offering by Visa Consulting & Analytics (VCA) provides actionable insights and recommendations to guide banks, fintechs, merchants, and businesses of all sizes on market fit, strategy, and implementation. As the stablecoin market cap surpasses $250 billion, Visa’s settlement volume has accelerated, reaching a $3.5 billion annualized run rate as of November 30. Businesses are turning to Visa’s new Stablecoins Advisory Practice to unlock growth opportunities. “Putting our members first has always been our mission, and we’re committed to exploring innovations that strengthen financial health and convenience for those we serve. Stablecoins may represent an opportunity to enhance speed and lower cost in payments, so with the support of Visa, we are evaluating how this technology could fit into our broader strategy to deliver meaningful value to ou
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 12:30:00 CET | Press Release
SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ
Safe Software Recognized as a Niche Player in 2025 Gartner® Magic Quadrant™ for Data Integration Tools15.12.2025 12:00:00 CET | Press Release
Safe Software, a global leader in data integration and transformation, has once again been recognized in the 2025 Gartner® Magic Quadrant™ for Data Integration Tools, marking the sixth consecutive year the company has been included in this prestigious report. Safe Software’s FME Platform has evolved well beyond its geospatial roots to become the only All-Data, Any-AI Integration Platform, empowering organizations worldwide to connect all data, applications, and AI technologies anywhere, at any scale, and with complete flexibility. With a community of more than 200,000 enthusiastic users and 25,000+ organizations in over 125 countries, FME continues to redefine data integration by delivering a no-code enterprise solution that unifies data movement, automation, and AI connectivity. “Our continued recognition reflects the trust of our customers and the innovation of our team,” said Don Murray, CEO and Co-Founder of Safe Software. “We’re proud to help organizations integrate data seamlessl
GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe15.12.2025 10:00:00 CET | Press Release
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GENESIS Pharma, a regional biopharma company focused on the commercialization of innovative medicines in Central and Eastern Europe, announces an exclusive agreementwithOtsuka Pharmaceutical Europe Ltd. (OPEL), the European operation of global healthcare company Otsuka Pharmaceutical Co., Ltd., for donidalorsen. Under the terms of the agreement, GENESIS Pharma will exclusively distribute and commercializedonidalorsen in fourteen markets: Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Greece, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. In November 2025, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for donidalorsen in the routine prevention of recurrent attacks of hereditary angioedema (HAE) in adults and adolescents aged 12 years and older. The CHMP opinion is c
BitGo yn Sicrhau Cymeradwyaeth OCC i Drosi i Fanc Ymddiriedolaeth Genedlaethol Siartredig Ffederal13.12.2025 02:13:00 CET | Pressmeddelande
Cyhoeddodd BitGo Holdings, Inc. (“BitGo”), y cwmni seilwaith asedau digidol, heddiw fod Swyddfa Rheolwr yr Arian Cyfred (“OCC”) wedi cymeradwyo ei gais i drosi BitGo Trust Company, Inc., cwmni ymddiriedolaeth siartredig De Dakota, i fanc cenedlaethol o'r enw BitGo Bank & Trust, National Association (N.A.). Gyda chymeradwyaeth OCC heddiw o'i drosi, mae is-gwmni Cwmni Ymddiriedolaeth BitGo bellach yn gweithredu fel BitGo Bank & Trust, National Association (N.A.). Bydd BitGo Bank & Trust, N.A. yn gweithredu o dan un gyfundrefn oruchwylio ffederal unffurf, gan ei alluogi i ddarparu'r eglurder, y llywodraethiant, a'r sicrwydd rheoleiddiol y mae sefydliadau'n eu disgwyl gan ymddiriedolwr a reoleiddir yn ffederal. Mae'r gymeradwyaeth hon yn atgyfnerthu safle BitGo fel sylfaen sefydliadol ar gyfer y system ariannol fodern, gan gyfuno goruchwyliaeth ar lefel banc â'r diogelwch, y cydymffurfiaeth, a'r graddadwyedd sy'n diffinio seilwaith BitGo. O dan siarter y banc cenedlaethol, ac yn amodol ar
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom